COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Thumbnail

Excess deaths in the US jumped 23% in 2020—COVID-19, heart disease and diabetes all played key roles

The study's authors warned that excess deaths may continue to rise if states don't learn any lessons from the last year. 

vaccine syringe covid-19 coronavirus

The blood clot plot continues: Countries suspend use of AstraZeneca COVID-19 vaccine in younger adults

The ongoing saga continues. Both Germany and Canada have now limited the use of the AstraZeneca vaccine among younger adults. 

Study confirms COVID-19 vaccines are effective

A new study has confirmed vaccines from Pfizer-BioNTech and Moderna are effective at preventing symptomatic COVID-19 cases.

Thumbnail

COVID relief bill slashed insurance premiums for early retirees

The American Rescue Plan Act of 2021, better known as the COVID-19 stimulus package, includes not only $1,400 in cash for every eligible American but also provisions to cut health insurance premiums. The move is proving a boon to retirees, Market Watch is reporting. 

 

coronavirus COVID-19 vaccine vaccination

COVID-19 vaccinations prevent infections among healthcare workers

Becoming infected with COVID-19 is unlikely once a person has been vaccinated, according to a study published in the New England Journal of Medicine.

AstraZeneca COVID-19 vaccine to get a blood clot warning in Canada

Officials confirmed, however, that they still believe the vaccine is safe and effective.  

Thumbnail

Pfizer COVID-19 vaccine sales to reach $15B

Pfizer, the drug manufacturer with one of just a few approved COVID-19 vaccines on the market, is set to pull in more than $15 billion in revenue in 2021 from its entrant, according to S&P Global.

 

A surprising number of healthcare pros are skeptical of the COVID-19 vaccine

About 4 in 10 healthcare workers haven’t gotten a COVID-19 vaccine yet, and more than 1 in 3 say they aren’t confident the vaccines have been thoroughly tested for safety and effectiveness, according to a new poll from The Washington Post and the Kaiser Family Foundation.